IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CATTANEO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.965
NA - Nord America 8.458
AS - Asia 4.245
SA - Sud America 141
OC - Oceania 53
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.911
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.216
GB - Regno Unito 4.150
CN - Cina 2.531
IT - Italia 2.528
DE - Germania 1.640
SE - Svezia 1.194
IN - India 514
UA - Ucraina 387
TR - Turchia 372
KR - Corea 370
FR - Francia 351
IE - Irlanda 330
RU - Federazione Russa 278
FI - Finlandia 233
CA - Canada 227
NL - Olanda 206
EU - Europa 171
DK - Danimarca 137
HK - Hong Kong 114
GR - Grecia 103
PL - Polonia 80
CO - Colombia 79
SG - Singapore 77
JP - Giappone 76
BE - Belgio 74
ES - Italia 73
CH - Svizzera 55
NO - Norvegia 45
AU - Australia 41
ID - Indonesia 41
VN - Vietnam 41
RO - Romania 30
BR - Brasile 29
CZ - Repubblica Ceca 19
PT - Portogallo 14
CL - Cile 13
SA - Arabia Saudita 13
BD - Bangladesh 12
MX - Messico 12
NZ - Nuova Zelanda 12
TW - Taiwan 12
AR - Argentina 11
IR - Iran 11
EG - Egitto 10
SC - Seychelles 10
ZA - Sudafrica 10
AT - Austria 7
IL - Israele 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
KZ - Kazakistan 6
PK - Pakistan 6
TH - Thailandia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
KE - Kenya 5
PH - Filippine 5
HR - Croazia 4
HU - Ungheria 4
IQ - Iraq 4
MC - Monaco 4
PE - Perù 4
EE - Estonia 3
SM - San Marino 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
DZ - Algeria 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
MU - Mauritius 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BZ - Belize 1
CY - Cipro 1
IS - Islanda 1
JO - Giordania 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NP - Nepal 1
QA - Qatar 1
UG - Uganda 1
VE - Venezuela 1
Totale 25.080
Salva come PNG Salva come JPEG
Città #
Southend 3.693
Chandler 1.138
Milan 1.042
Seattle 617
Beijing 592
Hanover 510
Fairfield 503
Wilmington 475
Shenzhen 458
Princeton 429
Dearborn 390
Ashburn 366
Dublin 327
Houston 314
Ann Arbor 310
Woodbridge 297
Frankfurt am Main 281
Jacksonville 249
Redmond 231
Nanjing 190
Mountain View 187
Cambridge 180
Hangzhou 166
Des Moines 138
Sakarya 136
Bengaluru 126
Berlin 116
New York 109
Redwood City 109
Boardman 105
Sunnyvale 98
Seoul 95
Athens 90
Phoenix 89
Toronto 86
Andover 84
Shanghai 80
Bogotá 79
Shenyang 79
Jinan 78
Ottawa 74
Somerville 72
Guangzhou 69
Helsinki 67
Serra 67
Changsha 61
Warsaw 60
Nanchang 59
Brussels 57
Hebei 52
San Diego 52
Hong Kong 48
Turin 45
Falls Church 43
Rome 40
Tianjin 40
Eitensheim 38
Bühl 37
Napoli 36
Kent 35
Hamburg 34
Istanbul 33
Naples 33
Ningbo 32
Fremont 31
London 31
Dong Ket 30
Barcelona 26
Bitonto 26
Jiaxing 25
Los Angeles 25
Padova 25
Kunming 22
Tokyo 22
Hefei 21
Verona 21
Zhengzhou 21
Central 19
Fuzhou 19
Silver Spring 19
Taizhou 19
Pavia 18
San Francisco 18
Washington 18
Medford 17
Singapore 17
Bologna 16
Kiez 16
Pittsburgh 16
Wuhan 16
Bergamo 15
Chengdu 15
Chicago 15
Haikou 15
Roxbury 15
São Paulo 15
Trento 15
Albano Sant'Alessandro 14
Auburn Hills 14
Madison 14
Totale 16.527
Salva come PNG Salva come JPEG
Nome #
The coding and long noncoding single-cell atlas of the developing human fetal striatum 666
The Enigma of Huntington’s Disease 558
ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease 548
Phylogenetic comparison of huntingtin homologues reveals the appearance of a primitive polyQ in sea urchin 515
Proteasome activator enhances survival of huntington's disease neuronal model cells 418
Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32(+) medium-sized spiny neurons 394
New label-free methods for protein relative quantification applied to the investigation of an animal model of Huntington Disease 391
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 376
Adaptation of NS cells growth and differentiation to high-throughput screening-compatible plates 366
Human cortical organoids expose a differential function of GSK3 on cortical neurogenesis 267
Expression of the JAK and STAT superfamilies in human meningiomas 257
Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes 250
Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington’s disease 249
Efficacy of Cholesterol Nose-to-Brain Delivery for Brain Targeting in Huntington's Disease 245
Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease 244
Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators 230
Neural stem cell systems: diversities and properties after transplantation in animal models of diseases 229
Successful sequencing of Huntington’s disease CAG microsatellite orthologs from museum collection specimens 220
REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells 219
Brain-derived neurotrophic factor in patients with Huntington's disease 202
Normal Function of Huntingtin 199
Allele-specific silencing as treatment for gene duplication disorders : Proof-of-principle in autosomal dominant leukodystrophy 198
Huntingtin gene and its CAG repeats number in Primates 193
Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease 191
Activation of the JAK/STAT pathway leads to proliferation of ST14A central nervous system progenitor cells 189
Wild-type huntingtin protects from apoptosis upstream of caspase-3 182
Expression and activation of SH2/PTB-containing ShcA adaptor protein reflects the pattern of neurogenesis in the mammalian brain 174
Turning REST/NRSF dysfunction in Huntington's disease into a pharmaceutical target 174
A CRISPR-strategy for the generation of a detectable fluorescent hESC reporter line (WAe009-A-37) for the subpallial determinant GSX2 174
Neural stem and progenitor cells: choosing the right Shc 168
Niche-independent symmetrical self-renewal of a mammalian tissue stem cell 167
Evaluation of histone deacetylases as drug targets in Huntington's disease models : Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model 167
Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models 166
Differentiation of human telencephalic progenitor cells into MSNs by inducible expression of Gsx2 and Ebf1 164
Expressed Alu repeats as a novel, reliable tool for normalization of real-time quantitative RT-PCR data 162
Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington's disease : a cross-validation study in Q175 knock-in mice 162
A gene network regulating lysosomal biogenesis and function 160
p66(ShcA) adaptor molecule accelerates ES cell neural induction 158
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery 158
An optimized experimental strategy for efficient conversion of embryonic stem (ES)-derived mouse neural stem (NS) cells into a nearly homogeneous mature neuronal population 156
An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin 155
Huntingtin’s neuroprotective activity occurs via inhibition of pro-caspase 9 processing 155
Characterization, developmental expression and evolutionary features of the huntingtin gene in the amphioxus Branchiostoma floridae 154
Huntingtin gene evolution in Chordata and its peculiar features in the ascidian Ciona genus 154
Setting the conditions for efficient, robust and reproducible generation of functionally active neurons from adult subventricular zone-derived neural stem cells 151
Brain-derived neurotrophic factor in neurodegenerative diseases 151
Dynamic and Cell-Specific DACH1 Expression in Human Neocortical and Striatal Development 150
EZ spheres: a stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs 150
Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells 147
Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons 147
C-FOS INDUCTION BY ESTROGEN IN SPECIFIC RAT-BRAIN AREAS 147
Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease 147
Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin 145
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntingtons disease 144
Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation 143
Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease 138
ACTIVATED ESTROGEN-RECEPTOR MEDIATES GROWTH ARREST AND DIFFERENTIATION OF A NEUROBLASTOMA CELL-LINE 138
Murine SEL-1L, a gene implicated in the ERAD pathway, is expressed in mouse embryo stem cells and is controlled by mmu-miR-183 during neural stem cell differentiation 137
The function of the neuronal proteins shc and huntingtin in stem cells and neurons - Pharmacologic exploitation for human brain diseases 136
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington disease 134
Pitfalls in the detection of cholesterol in Huntington’s disease models 132
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF 132
Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells 131
Induced pluripotent stem cells from patients with Huntington’s disease: show CAG repeat-expansion-associated phenotypes 131
Normal huntingtin function: an alternative approach to Huntington's disease 129
Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease 129
Human pluripotent stem cell differentiation into authentic striatal projection neurons 129
ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migration 128
Early and transient alteration of adenosine A(2A) receptor signaling in a mouse model of Huntington disease 127
Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease : restoration by the neuroprotective compound CEP-134 127
Molecular and functional definition of the developing human striatum 127
SREBP2 delivery to striatal astrocytes normalizes transcription of cholesterol biosynthesis genes and ameliorates pathological features in Huntington’s Disease 127
From target identification to drug screening assays for neurodegenerative diseases 125
Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death 125
Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells 125
Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages 124
Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease 124
A DNA transposon-based approach to functional screening in neural stem cells 124
Neural stem cell systems : physiological players or in vitro entities? 122
CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice 120
Aberrant A(2A) receptor function in peripheral blood cells in Huntington's disease 120
Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease 118
Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis 118
RUES2 hESCs exhibit MGE-biased neuronal differentiation and muHTT-dependent defective specification hinting at SP1 118
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease 118
Nanoparticles for transport across the blood-brain barrier 118
Comparative expression profiles of ShcB and ShcC phosphotyrosine adapter molecules in the adult brain 117
Stem Cell-Derived Human Striatal Progenitors Innervate Striatal Targets and Alleviate Sensorimotor Deficit in a Rat Model of Huntington Disease 117
hiPSCs for predictive modelling of neurodegenerative diseases : dreaming the possible 116
Shc3 affects human high-grade astrocytomas survival 115
Variations in the levels of the JAK/STAT and ShcA proteins in human brain tumors 115
Growth hormone regulation of growth hormone-releasing hormone gene expression 115
SEL-1L influences self-renewal in neural stem cells 114
A transgenic minipig models of Huntington’s disease 114
Whole body cholesterol metabolism is impaired in Huntington's disease 113
New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research 112
Wnt-5a expression in the rat neuronal progenitor cell line ST14A 112
Cholesterol-laden brain-permeable nanoparticles support long-lasting cognitive recovery and motor amelioration in the slow-progressing zQ175DN mouse model of Huntington’s Disease 111
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation 110
Cholesterol dysfunction in neurodegenerative diseases : is Huntington's disease in the list? 110
Totale 18.068
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.090
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019677 0 0 0 0 0 0 0 0 0 0 431 246
2019/20203.657 489 223 195 198 280 562 509 189 385 401 136 90
2020/20213.315 235 247 269 107 262 314 268 182 406 212 603 210
2021/20223.534 193 143 135 235 348 254 325 269 369 352 309 602
2022/20234.307 630 467 384 523 426 684 136 293 390 89 181 104
2023/20242.497 113 193 664 197 585 105 144 193 98 190 15 0
Totale 26.459